Table 1 Clinical characteristics

Age (years)

55.62 ± 9.30

54.56 ± 10.64

57.55 ± 9.21

60.08 ± 13.39

58.24 ± 10.61

0.254

Male, n (%)

19(45.2%)

25(69.4%)

14(70.0%)

16(66.6%)

31(68.8%)

0.111

Height (cm)

163.64 ± 6.50

166.67 ± 7.70

165.80 ± 7.07

165.08 ± 9.78

164.31 ± 6.95

0.442

Weight (kg)

62.27 ± 6.33

66.64 ± 10.96

66.93 ± 9.67

64.21 ± 12.54

65.47 ± 11.78

0.345

BSA (m²)

1.64 ± 0.105

1.71 ± 0.174

1.72 ± 0.156

1.68 ± 0.205

1.69 ± 0.184

0.330

HT duration (years)

-

5.69 ± 3.54

7.46 ± 5.22

9.92 ± 7.70

5.28 ± 1.91

0.064

Anti-hypertensive medications, n (%)

 CCB

-

9(25.0%)

7(35.0%)

3(12.5%)

7(15.6%)

0.205

 Beta-blocker

-

3(8.3%)

0(0)

1(4.2%)

2(4.4%)

0.567

 ACE-I

-

1(2.8%)

0(0)

2(8.3%)

2(4.4%)

0.538

 ARB

-

3(8.3%)

6(30.0%)

5(20.8%)

4(8.9%)

0.074

 Diuretic

-

0(0)

0(0)

1(4.2%)

1(2.2%)

0.567

 SBP (mm Hg)

116.26 ± 10.34

137.97 ± 14.92^a(P < 0.001)

135.37 ± 13.80^a(P < 0.001)

149.50 ± 21.38^a(P < 0.001)

141.88 ± 21.89^a(P < 0.001)

 < 0.001

 DBP(mm Hg)

73.81 ± 8.34

88.03 ± 12.04^a(P < 0.001)

85.34 ± 8.69^a(P = 0.001)

87.63 ± 14.07^a(P < 0.001)

86.35 ± 15.18^a(P < 0.001)

 < 0.001

 Heart rate (b.p.m)

69.60 ± 12.41

69.59 ± 10.89

71.80 ± 10.16

68.88 ± 12.27

72.31 ± 15.47

0.760